Intellectual Property India Publishes Patent Application for 'Antibodies Against Msln And Methods Of Use Thereof' Filed by Dana-Farber Cancer Institute, Inc.

MUMBAI, India, June 20 -- Intellectual Property India has published a patent application (202517023148 A) filed by Dana-Farber Cancer Institute, Inc., Boston, on March 15, for 'antibodies against msln and methods of use thereof.'

Inventor(s) include Marasco, Wayne A.; and Chang, Matthew.

The application for the patent was published on June 20, under issue no. 25/2025.

According to the abstract released by the Intellectual Property India: "The present invention comprises human antibodies that bind to mesothelin (MSLN) protein. The antibodies can be used to treat cancer."

The patent application was internationally filed on Aug. 15, 2023, under International application No.PCT/US2023/030268.

Disclaimer: Curated by HT Syndication.